STRS Ohio’s BioAtla BCAB Stock Holding History

STRS Ohio’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-74	Closed	-$108K	–	2199
2021 Q3	$108K	Buy	74 +12	+19%	+$23.4K	﹤0.01%	1926
2021 Q2	$131K	Buy	62 +6	+11%	+$13.6K	﹤0.01%	1921
2021 Q1	$142K	Buy	+56	New	+$144K	﹤0.01%	1868

Other funds holding BCAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

STRS Ohio's BCAB Position: Q4 2021 in Review

STRS Ohio sold out of BioAtla (BCAB) in Q4 2021, closing a stake of 74 shares — an estimated $108K sold.

STRS Ohio first reported a position in BCAB in Q1 2021 and held it in 3 quarters. The position peaked at $142K in Q1 2021. 79 funds tracked by Wall St. Rank hold BCAB as of Q4 2021.

STRS Ohio reported no remaining BioAtla position as of Q4 2021 after selling out during the quarter.
STRS Ohio sold 74 BioAtla shares in Q4 2021, an estimated $108K.
STRS Ohio first reported a position in BioAtla in Q1 2021 and held it in 3 quarters.
STRS Ohio's BioAtla position peaked at $142K in Q1 2021.
79 funds tracked by Wall St. Rank held BioAtla as of Q4 2021.

Based on STRS Ohio's 13F filing for Q4 2021, filed 24 Jan 2022.